피질골용 스크류 시장 : 세계 예측(2026-2032년)

The Cortical Bone Screw Market is projected to grow by USD 1,682.93 million at a CAGR of 10.54% by 2032.

Cortical Bone Screws: Executive Summary and Market Context

Cortical bone screws are fixation devices designed for purchase in dense cortical bone and are used across trauma, orthopedic, reconstructive, and selected dental procedures. Demand is shaped by fracture incidence, surgical volumes, implant design, material performance, hospital procurement practices, and clinicians' requirements for reliable fixation and predictable handling.

How Surgical Practice and Device Design Are Transforming Cortical Fixation

The landscape is shifting toward anatomically compatible systems, refined thread geometries, improved driver interfaces, and instrumentation that supports efficient placement. Greater emphasis on minimally invasive techniques, standardization of surgical workflows, radiographic compatibility, and implant traceability is influencing product development and procurement. Regulatory scrutiny, sterilization requirements, and evidence supporting biocompatibility and mechanical performance remain central to adoption.

Artificial Intelligence Is Strengthening Planning, Documentation, and Quality Control

Artificial intelligence is contributing most directly through imaging interpretation, fracture classification, preoperative planning, and workflow support. Data-assisted tools can help clinicians evaluate cortical thickness, identify fixation corridors, and compare procedural options, while computer vision and analytics may improve inventory control, manufacturing inspection, and adverse-event surveillance. Clinical validation, interoperability, cybersecurity, explainability, and human oversight remain necessary before AI-supported recommendations can be integrated safely into routine fixation decisions.

Regional Insights: Different Health Systems Shape Adoption Priorities

North America is characterized by advanced trauma infrastructure, stringent device oversight, and demand for differentiated instrumentation and clinical evidence. Europe emphasizes conformity assessment, cross-border procurement, hospital efficiency, and sustainability, while the European Union's regulatory framework increases the importance of documentation and post-market monitoring. Asia-Pacific combines expanding surgical capacity with diverse reimbursement and regulatory environments, with Australia, China, India, Japan, and South Korea reflecting distinct pathways to adoption. Latin America is influenced by public-sector purchasing, import requirements, and uneven access to specialist care. The Middle East is supported by investment in tertiary hospitals and medical tourism, while Africa shows varied access shaped by infrastructure, training capacity, and supply-chain reliability.

Group Insights: Trade, Regulation, and Procurement Networks Matter

ASEAN markets present a combination of growing healthcare capacity, varied regulatory maturity, and cross-border supply-chain considerations. BRICS members reflect large and diverse healthcare systems, with local manufacturing, affordability, and public procurement particularly relevant. The European Union prioritizes coordinated regulatory compliance, clinical documentation, and supply continuity. G7 systems generally place strong weight on evidence, quality management, and hospital value analysis. GCC countries are influenced by centralized purchasing, specialist-care investment, and import coordination. NATO members may benefit from aligned quality expectations and resilient medical supply planning, although national healthcare and procurement systems remain distinct.

Country Insights: Regulatory and Clinical Priorities Across Key Markets

Australia emphasizes regulated device supply and coordinated hospital procurement. Brazil combines substantial clinical need with complex public and private purchasing channels. Canada prioritizes evidence, regulatory compliance, and provincial procurement structures. China is shaped by domestic manufacturing capacity, centralized purchasing initiatives, and evolving device oversight. France, Germany, Italy, and Spain operate within European regulatory requirements while differing in reimbursement, procurement, and hospital organization. India presents broad clinical demand alongside price sensitivity and expanding local production. Japan values rigorous quality, clinician confidence, and established approval pathways. Mexico is influenced by public-sector purchasing, import processes, and regional disparities. Russia's environment is affected by regulatory, trade, and supply-chain conditions. South Korea combines advanced hospitals with quality-focused procurement. The United Kingdom emphasizes evidence, hospital value assessment, and post-market assurance. The United States is characterized by sophisticated trauma care, regulatory review, hospital contracting, and demand for workflow-efficient systems.

Action Priorities for Leaders in Cortical Bone Screw Systems

Leaders should align product portfolios with anatomically appropriate indications, surgeon workflow, and documented mechanical and biocompatibility performance. They should strengthen regulatory files, post-market surveillance, instrument reliability, and supply continuity while adapting evidence packages to local requirements. Partnerships with hospitals and clinicians can support training, usability assessment, and responsible adoption. Investments in digital planning should remain clinically validated, interoperable, and transparent. Regional strategies should account for procurement structures, reimbursement, service capabilities, and affordability rather than relying on a single global approach.

Research Methodology for the Cortical Bone Screw Executive Summary

This summary uses a structured qualitative framework centered on the clinical role of cortical bone screws, device-design trends, regulatory considerations, healthcare delivery conditions, procurement dynamics, and technology adoption. Regional, group, and country observations are synthesized from established characteristics of healthcare systems, medical-device governance, surgical practice, and supply-chain environments. No market estimates, market shares, forecasts, or company-specific claims are included. Interpretations should be validated against current regulatory notices, peer-reviewed clinical evidence, procurement policies, and local hospital practice before being used for investment or product decisions.

Conclusion: Evidence, Usability, and Access Will Define Sustainable Progress

The cortical bone screw landscape is being shaped by the intersection of dependable fixation, refined surgical workflow, regulatory accountability, and unequal access to orthopedic care. The strongest opportunities for responsible progress lie in clinically relevant design, robust evidence, dependable instrumentation, and regionally tailored implementation. Artificial intelligence can enhance planning and quality systems, but it should complement-not replace-surgeon judgment and established safety controls.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cortical Bone Screw Market, by Material

• 7.1. Introduction
• 7.2. Bioabsorbable
• 7.3. Stainless Steel
• 7.4. Titanium

8. Cortical Bone Screw Market, by Product Type

• 8.1. Introduction
• 8.2. Non Self Tapping
• 8.3. Self Tapping

9. Cortical Bone Screw Market, by Application

• 9.1. Introduction
• 9.2. Foot & Ankle Surgery
  • 9.2.1. Hindfoot
  • 9.2.2. Midfoot
• 9.3. Spinal Surgery
  • 9.3.1. Cervical
  • 9.3.2. Thoracolumbar
• 9.4. Sports Medicine
• 9.5. Trauma
  • 9.5.1. Lower Extremity
  • 9.5.2. Upper Extremity

10. Cortical Bone Screw Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Orthopedic Clinics

11. Cortical Bone Screw Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Direct Sales
• 11.3. Distributors

12. Cortical Bone Screw Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Cortical Bone Screw Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Cortical Bone Screw Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Alphatec Holdings, Inc.
• 16.2. Arthrex, Inc.
• 16.3. B. Braun Melsungen AG
• 16.4. ConMed Corporation
• 16.5. DePuy Synthes, Inc.
• 16.6. Globus Medical, Inc.
• 16.7. Innovasis, Inc.
• 16.8. Medtronic plc
• 16.9. NuVasive, Inc.
• 16.10. Orthofix Medical Inc.
• 16.11. RTI Surgical Holdings, Inc.
• 16.12. Smith & Nephew plc
• 16.13. Spinal Elements, Inc.
• 16.14. Stryker Corporation
• 16.15. Xtant Medical Holdings, Inc.
• 16.16. Zavation Medical Products, LLC
• 16.17. Zimmer Biomet Holdings, Inc.

17. Key Experts